predicant


Also found in: Encyclopedia.
Related to predicant: predicament

predicant

(ˈprɛdɪkənt)
adj
(Ecclesiastical Terms) of or relating to preaching
n
1. (Ecclesiastical Terms) a member of a religious order founded for preaching, esp a Dominican
2. (Protestantism) a variant spelling of predikant
[C17: from Latin praedicāns preaching, from praedicāre to say publicly; see predicate]
Mentioned in ?
References in periodicals archive ?
Castam me predicant, qui non deprehendunt ypocritam; munditiam carnis conferunt in virtutem: cum non sit corporis sed animi virtus, aliquid laudis apud homines habens, nichil apud Deum mereor, qui cordis et renum probator est et in abscondito videt.
is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen.
The acquired pending patent was held previously by Predicant Biosciences, which in a June 2006 merger became Pathwork Diagnostics, a genomics-based diagnostics company focused on oncology.
Caliper and Predicant Biosciences Forge Licensing Agreement II-68
Prior to joining Xceed, Deems was vice president, development and operations at Predicant Biosciences and vice president, product development at Exact Sciences.
July 6 /PRNewswire/ -- With new venture capital funding, Predicant Biosciences has acquired San Jose-based Pathwork Informatics and named the merged company Pathwork Diagnostics, the new corporation announced today.
General Partner of the Vertical Group; Deborah Neff, President and Chief Executive Officer of Predicant Bioscience, Inc.
Pathwork Diagnostics (formerly Predicant Biosciences)
Tananbaum has helped found or led financings for numerous biotechnology, pharmaceutical and healthcare service companies, including Infinity Pharmaceuticals, Jazz Pharmaceuticals, PatientCare, Predicant, CompHealth, Nanosys, Vanda Pharmaceuticals and Vitae Pharmaceuticals.
most recently serving as vice president of finance for Predicant Biosciences, Inc.
Predicant Biosciences today announced the appointment of Richard Bastiani, Ph.
5 million of debt financing to Predicant Biosciences, an emerging life sciences company developing minimally invasive technology for identifying and assaying protein biomarkers.